Literature DB >> 15686140

The effects of hormones of the hypothalamo-hypophyseal-adrenal, renin-angiotensin, and thyroid hormone systems on the formation of dyscirculatory encephalopathy.

V I Skvortsova1, I A Platonova, T V Tvorogova, O V Volkovenko, L I Demidova, I V Ostrovtsev.   

Abstract

Measurements were made of plasma levels of free (f) thyroxine (fT4), triiodothyronine (fT3), thyrotropic hormone (TSH), adrenocorticotrophic hormone (ACTH), aldosterone, and renin in patients with dyscirculatory encephalopathy (DE). Their influences on the development of chronic circulatory insufficiency were assessed. A total of 39 patients were studied (aged 45-73 years) with DE stages I and II, without acute or chronic (in the exacerbation phase) somatic illness. These observations showed that diffuse lesions of brain tissues of different severities were accompanied by the following changes in thyroid homeostasis: 1) significant combined increases in TSH without alteration to the "fT3-TSH" negative feedback regulatory mechanism in patients with stage I DE; 2) significant combined decreases in TSH levels with marked suppression of the conversion of thyroxine into triiodothyronine and an interaction with impairments in the "fT3-hypophysis" system in patients with stage II DE. In addition, there were changes (increases) in cortisol levels with simultaneous decreases in renin levels in patients with stage II DE as compared with patients with stage I DE. Correlation analysis demonstrated the absence of any relationship between the age of the patients, the state of hormonal homeostasis, and the extent of vascular stenosis. These results suggest a role for hormones of the hypothalamo-hypophyseal-adrenal, thyroid, and renin-angiotensin systems in the mechanism by which DE develops as well as the possibility of using tests for these hormones as additional criteria for assessing the severity of diffuse brain lesions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15686140     DOI: 10.1023/b:neab.0000042653.86706.2a

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  45 in total

1.  A potential role of activated NF-kappa B in the pathogenesis of euthyroid sick syndrome.

Authors:  T Nagaya; M Fujieda; G Otsuka; J P Yang; T Okamoto; H Seo
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 2.  Interleukin-1-induced plasticity of hypothalamic CRH neurons and long-term stress hyperresponsiveness.

Authors:  F J Tilders; E D Schmidt
Journal:  Ann N Y Acad Sci       Date:  1998-05-01       Impact factor: 5.691

3.  Serum lipoproteins and apolipoprotein E in infants with congenital hypothyroidism.

Authors:  T Ciomartan; T Asami; M Uchiyama
Journal:  Pediatr Int       Date:  1999-06       Impact factor: 1.524

4.  Severe liver degeneration in mice lacking the IkappaB kinase 2 gene.

Authors:  Q Li; D Van Antwerp; F Mercurio; K F Lee; I M Verma
Journal:  Science       Date:  1999-04-09       Impact factor: 47.728

5.  Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway.

Authors:  F S Lee; J Hagler; Z J Chen; T Maniatis
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

Review 6.  Angiotensin II and gene expression in the kidney.

Authors:  S Klahr; J Morrissey
Journal:  Am J Kidney Dis       Date:  1998-01       Impact factor: 8.860

7.  Prolonged effects of tumor necrosis factor-alpha on anterior pituitary hormone release.

Authors:  G Harel; D S Shamoun; J P Kane; J A Magner; M Szabo
Journal:  Peptides       Date:  1995       Impact factor: 3.750

8.  Relationship between mental impairment and HPA axis activity in dementia disorders.

Authors:  J Balldin; K Blennow; G Bråne; C G Gottfries; I Karlsson; B Regland; A Wallin
Journal:  Dementia       Date:  1994 Sep-Oct

9.  Hypothalamic dysfunction in dementia.

Authors:  C G Gottfries; J Balldin; K Blennow; G Bråne; I Karlsson; B Regland; A Wallin
Journal:  J Neural Transm Suppl       Date:  1994

Review 10.  Mechanisms for inducible control of angiotensinogen gene transcription.

Authors:  A R Brasier; J Li
Journal:  Hypertension       Date:  1996-03       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.